Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Not Confirmed
Not Confirmed
04-05 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Industry Trade Show
Not Confirmed
04-05 March, 2026
Digital content

18 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260218721069/en/Precision-BioSciences-Announces-Presentation-at-the-2026-Muscular-Dystrophy-Association-Clinical-Scientific-Conference

11 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260211634383/en/Precision-BioSciences-Receives-U.S.-FDA-Clearance-of-Investigational-New-Drug-Application-for-First-in-Class-PBGENE-DMD-for-Treatment-of-Duchenne-Muscular-Dystrophy

12 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260112331937/en/Precision-BioSciences-Sets-Strategic-Priorities-for-2026-Focused-on-Continued-Advancement-of-Clinical-Stage-Programs-PBGENE-HBV-for-Chronic-Hepatitis-B-and-PBGENE-DMD-for-Duchenne-Muscular-Dystrophy

23 Dec 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251223432355/en/Precision-BioSciences-Announces-Grant-of-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4

19 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251119821874/en/Precision-BioSciences-Announces-Presentation-of-Clinical-Data-from-the-ELIMINATE-B-Trial-at-HEP-DART-2025

10 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251110273856/en/Precision-BioSciences-Presents-Late-Breaking-Phase-1-PBGENE-HBV-Data-at-AASLD-The-Liver-Meeting-Showing-Safety-Tolerability-and-Cumulative-Dose-Dependent-Antiviral-Activity-in-First-Three-Cohorts
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE